Indian Pharma industry moving towards formulations

Indian Pharma industry is slowing moving up the value chain. Earlier it used to manufacture active pharmaceutical ingredient at low cost compared to world. Now with competition from China, which provides API at 15-20% low cost, it makes sense to shift focus elsewhere. Many top companies like Lupin, Novartis, Ranbaxy have less revenue stream from API than from formulations. There could also be the reason that formulation business has grown faster than APIs for some companies. API is low scale commodity with low margin. Moreover, with a large number of patent expiries in developed markets like the US and Europe, Indian companies, with skills to develop and manufacture low-cost generic drugs, see a much more lucrative opportunity there than utilising their capacities for manufacturing APIs.
Read More

  • No Image
    Nectar Lifesciences Ltd

    Nectar Lifesciences Ltd. (NLL) is a knowledge driven organization which constitutes a vital part of fast growing Indian Pharmaceutical Industry. In a short span of existence, NL

  • No Image
    Neelam Phyto Extracts

    Neelam Phyto Extracts is a producer of Calcium Sennosides (CAS: 62211-03-4),Essential Oils, Herbal Extracts, Natural Essential Oils, Oil And Oleoresins (Spice),

  • No Image
    Neuland Laboratories Ltd

    Neuland Laboratories Ltd is headquartered in Hyderabad, India. The company manufactures active pharmaceutical ingredients (APIs) and provides end-to-end solution for the pharma

  • No Image
    NGL Fine Chem Ltd

    NGL Fine-Chem Ltd is a manufacturer of pharmaceuticals and intermediates for usage in veterinary and human health.

  • No Image
    Niranjan Laboratory

    Niranjan Laboratory is engaged in production of bactericides, 2-Bromo-2-Nitro-1, 3-Propanediol, Bronopol, 2,2-Dibromo -3-nitrilopropionamide (DBNPA), 1,2,4-Triazole, Allantoin,